Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves’ disease
- 1 October 1981
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 4 (4) , 399-402
- https://doi.org/10.1007/bf03348302
Abstract
Out of 54 patients with hyperthyroid Graves’ disease 35 remained euthyroid after treatment with antithyroid agents and have been continuously followed from 1 to 9 yr (4.85 ± 2.55 yr, mean ± SD). In 4 patients an exaggerated TSH response to TRH developed from 30 to 111 months after interrupting the treatment and one of them became hypothyroid 60 months (5.0 yr) thereafter. The annual incidence of subclinical hypothyroidism (exaggerated response to TRH) as calculated from the total number of observation yr was 2.5% and that of overt hypothyroidism was 0.6%. These figures are similar to those reported recently in 2 retrospective studies.This publication has 24 references indexed in Scilit:
- Carbimazole and the Autoimmune Response in Graves' DiseaseNew England Journal of Medicine, 1980
- Hypothyroidism as a Late Sequela in Patients with Graves' Disease Treated with Antithyroid AgentsJournal of Clinical Investigation, 1979
- ON THE EFFECT OF THYROTROPIN AND IMMUNOGLOBULINS RELATED TO GRAVES' DISEASE ON THYROTROPIN SYNTHESIS AND SECRETIONClinical Endocrinology, 1978
- SPECTRUM OF THYROID FUNCTION IN PATIENTS REMAINING IN REMISSION AFTER ANTITHYROID DRUG THERAPY FOR THYROTOXICOSISThe Lancet, 1977
- NATURAL COURSE OF SYMPTOMLESS AUTOIMMUNE THYROIDITISThe Lancet, 1975
- THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASEThe Lancet, 1974
- Grades of HypothyroidismBMJ, 1973
- OPHTHALMIC GRAVES' DISEASE: Diagnosis and PathogenesisThe Lancet, 1970
- The Thyro‐Hypophysial Syndrome.Acta Medica Scandinavica, 1957
- HYPEROPHTHALMOPATHIC GRAVES' DISEASEAnnals of Internal Medicine, 1945